ULTRA-ORPHAN MEDICINAL PRODUCTS ASSESSMENT: COMPARISON OF THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) AND THE INSTITUTE OF CLINICAL AND ECONOMIC REVIEW (ICER) HTA FRAMEWORKS

被引：0

作者：

Dusza, M. ^{[1
]}

Kloc, K. ^{[1
]}

Remuzat, C. ^{[2
]}

Francois, C. ^{[3
]}

Toumi, M. ^{[3
]}

机构：

[1] Creativ Ceut, Krakow, Poland

[2] Creativ Ceut, Lyon 75, France

[3] Aix Marseille Univ, Marseille, France

来源：

VALUE IN HEALTH | 2019年 / 22卷

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PRO98

引用

页码：S859 / S859

页数：1

共 50 条

[1] ANALYSIS OF NICE AND US ICER HTA OUTCOMES FOR ULTRA-ORPHAN MEDICINAL PRODUCTS
Dusza, M.
Kloc, K.
Remuzat, C.
Francois, C.
Toumi, M.
[J]. VALUE IN HEALTH, 2019, 22 : S861 - S861
[2] Evaluation of Advanced Therapy Medicinal Products by the National Institute for Health and Care Excellence (NICE): An Updated Review
Ana-Catarina Pinho-Gomes
John Cairns
[J]. PharmacoEconomics - Open, 2022, 6 : 147 - 167
[3] Evaluation of Advanced Therapy Medicinal Products by the National Institute for Health and Care Excellence (NICE): An Updated Review
Pinho-Gomes, Ana-Catarina
Cairns, John
[J]. PHARMACOECONOMICS-OPEN, 2022, 6 (02) : 147 - 167
[4] DIFFERENT VALUES IN COST-EFFECTIVENESS RESEARCH: INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW (ICER) VS. THE NATIONAL INSTITUTE FOR CARE EXCELLENCE (NICE)
Liden, D.
Jaksa, A.
[J]. VALUE IN HEALTH, 2016, 19 (07) : A501 - A501
[5] A COMPARISON OF HTA RECOMMENDATIONS FOR CANCER TREATMENT TECHNOLOGIES PUBLISHED BY AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT (AHTAPOL) AND NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE)
Kiljan, A.
Kolasa, K.
Hermanowski, T.
[J]. VALUE IN HEALTH, 2010, 13 (07) : A280 - A281
[6] A COMPARISON OF HTA RECOMMENDATIONS ISSUED BY AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND (AHTAPOL) AND NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE) IN THE UK - CONSIDERATION OF SOCIAL IMPLICATIONS IN HTA
Ceglowska, U.
Kolasa, K.
Hermanowski, T.
[J]. VALUE IN HEALTH, 2011, 14 (07) : A355 - A355
[7] THE INCREASING USE AND ACCEPTANCE OF ALTERNATIVE STATISTICAL APPROACHES TO INDIRECT COMPARISON IN THE NATIONAL INSTITUTE OF HEALTH AND CARE EXCELLENCE (NICE) HEALTH TECHNOLOGY ASSESSMENT (HTA) SUBMISSION PROCESS
Pooley, N.
Marjenberg, Z.
Embleton, N.
Langham, S.
[J]. VALUE IN HEALTH, 2019, 22 : S814 - S814
[8] QUANTITATIVE ASSESSMENT OF TECHNICAL ERRORS FOUND IN ECONOMIC MODELS SUBMITTED TO THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE)
Radeva, D.
Hopkin, G.
Naci, H.
Borrill, J.
Osipenko, L.
Mossialos, E.
[J]. VALUE IN HEALTH, 2018, 21 : S196 - S196
[9] IS THE INSTITUTE OF CLINICAL AND ECONOMIC REVIEW (ICER) SET UP FOR SUCCESS? A COMPARISON BETWEEN ICER AND EX-US HTA AGENCIES
Skolas, K.
Pruefert, A.
Yee, S.
van Engen, A.
[J]. VALUE IN HEALTH, 2016, 19 (07) : A476 - A476
[10] Implementing the clinical standards of the National Institute for Health and Care Excellence (NICE) bipolar clinical guideline
Tremblay, M.
Palin, S.
[J]. EUROPEAN PSYCHIATRY, 2016, 33 : S20 - S21

← 1 2 3 4 5 →